Lidokain Noridem (Lidocaine Hydrochloride Monohydrate)

Lidocaine blocks voltage‑gated sodium channels on nerve membranes, preventing the initiation and spread of action potentials. This stabilises the neuronal membrane and stops nerve impulse transmission, resulting in reversible loss of sensation in the treated area.

The appropriate dose of Lidokain Noridem is determined by the prescribing clinician based on the specific procedure, route of administration, patient weight, age, and overall health status. Dosing guidelines are provided in the product’s prescribing information.

Safety data for lidocaine in pregnancy and lactation are limited. It should only be used when the potential benefit to the mother outweighs any possible risk to the fetus or infant, and the decision should be made by a qualified healthcare professional.

To order, submit an enquiry on the product page at gnhindia.com specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including any cold‑chain needs) and required import documentation.

Lidocaine has a rapid onset and moderate duration of action, making it suitable for many short‑ to medium‑duration procedures. Compared with longer‑acting agents such as bupivacaine, lidocaine provides quicker recovery of sensation but may require repeat dosing for prolonged analgesia.

Lidokain Noridem should be stored below 25 °C, protected from moisture and light, and kept in its original packaging until use. Do not freeze the product, and ensure the container is sealed to maintain sterility.

The product is supplied as a sterile injectable solution and is administered by a qualified healthcare professional via epidural, intradermal or intramuscular injection, depending on the intended clinical use and the patient’s condition.

Serious risks include allergic reactions such as anaphylaxis, cardiac arrhythmias, methemoglobinemia, and central nervous system toxicity that can manifest as seizures. Immediate medical attention is required if any of these events occur.

Patients with known hypersensitivity to lidocaine or other amide‑type local anesthetics, those with severe heart block, uncontrolled cardiac conduction disorders, or individuals for whom the risk of systemic toxicity outweighs the benefit should avoid using Lidokain Noridem.